Lv3
240 积分 2024-10-13 加入
Immune checkpoint inhibitors and the liver: balancing therapeutic benefit and adverse events
18小时前
已完结
Hepatic sinusoidal obstruction syndrome after immune-checkpoint-inhibitor therapy: when the liver sends SOS
6天前
已完结
Outcomes of immune checkpoint inhibitor‐induced liver toxicity managed by hepatologists in a multidisciplinary toxicity team
10天前
已完结
An algorithm based on immunotherapy discontinuation and liver biopsy spares corticosteroids in two thirds of cases of severe checkpoint inhibitor‐induced liver injury
13天前
已完结
Programmed cell death protein-1 (PD-1) inhibitor therapy in patients with advanced melanoma and preexisting autoimmunity or ipilimumab-triggered autoimmunity
3个月前
已完结
Hepatotoxicity induced by immune checkpoint inhibitors: a comprehensive review including current and alternative management strategies
5个月前
已完结
Safety profile of nivolumab (NIVO) in patients (pts) with advanced melanoma (MEL): A pooled analysis
6个月前
已关闭
Prevention of Osteoporosis Associated With Chronic Glucocorticoid Therapy
6个月前
已完结
Prevention of Osteoporosis Associated With Chronic Glucocorticoid Therapy
6个月前
已关闭
Risk factors for immune-mediated hepatotoxicity in patients with cancer treated with immune checkpoint inhibitors: a systematic review and meta-analysis
9个月前
已完结
皖公网安备34019202002308
